Bontia, Rebecca L.
HRN: 19-05-94 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/26/2022
CEFTRIAXONE 1G (VIAL)
06/26/2022
07/02/2022
IVTT
2g
Q24
Pulmonary Infiltrates
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes